Document is current
Any future updates will be listed below
-
Authors
Emiloju, Oluwadunni
Miao, Ruoyu
Alese, Olatunji
- License Information
-
More Information
Article History
Received: 23 April 2025
Accepted: 25 April 2025
First Online: 22 May 2025
Disclosure
: Olatunji Alese Research funding was provided by Taiho Oncology, Ipsen Pharmaceuticals, GSK, Bristol Myers Squibb, Boehringer Ingelheim, Xencor Inc., Cue Biopharma, Inc., Merck, Inhibitex Inc, Arcus Biosciences Inc. Consulting/Advisory Role: Ipsen Pharmaceuticals, GSK, Cue Biopharma, Inc., Abbvie, Taiho, Bristol Myers Squibb, AstraZeneca, Exelixis, Takeda, Boehringer Ingelheim, and Loxo Oncology Independent Data Monitoring Committee: Compass Therapeutics, Inc.
